Episode

How AI Changed Cardiac Clinical Practice and Outcomes

Podcast
A Health Podyssey
Published
Mar 17, 2026
Duration seconds
1241
Processing state
not_requested
Canonical source
https://share.transistor.fm/s/c2767959
Audio
https://media.transistor.fm/c2767959/bfe847b4.mp3
JSON
/v1/public/podcasts/a-health-podyssey-1366621/episodes/how-ai-changed-cardiac-clinical-practice-and-outcomes
Markdown
/podcast/a-health-podyssey-1366621/how-ai-changed-cardiac-clinical-practice-and-outcomes.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/a-health-podyssey-1366621/episodes/how-ai-changed-cardiac-clinical-practice-and-outcomes/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/a-health-podyssey-1366621/how-ai-changed-cardiac-clinical-practice-and-outcomes.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

Health Affairs ' Rob Lott interviews Anna Zink of Tufts University about on her recent paper examining studies of an FDA‑approved cardiac diagnostic AI tool , fractional flow reserve derived from computed tomography. They discuss how the tool shifts testing patterns, raises some costs, reduces invasive procedures, and may improve outcomes—along with what it all means for Medicare reimbursement and the future of AI regulation. Order the March 2026 issue of Health Affairs . Currently, more than 70 percent of our content is freely available - and we'd like to keep it that way. With your support , we can continue to keep our digital publication Forefront and podcast for everyone.